|
1
|
Zhu RX, Seto WK, Lai CL and Yuen MF:
Epidemiology of hepatocellular carcinoma in the Asia-Pacific
region. Gut Liver. 10:332–339. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ge S and Huang D: Systemic therapies for
hepatocellular carcinoma. Drug Discov Ther. 9:352–362. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Waller LP, Deshpande V and Pyrsopoulos N:
Hepatocellular carcinoma: A comprehensive review. World J Hepatol.
7:2648–2663. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Toy M, Salomon JA, Jiang H, Gui H, Wang H,
Wang J, Richardus JH and Xie Q: Population health impact and
cost-effectiveness of monitoring inactive chronic hepatitis B and
treating eligible patients in Shanghai, China. Hepatology.
60:46–55. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu J, Wang Y, Zhang D, Liu B and Ou Q:
Comparison of survival and quality of life of hepatectomy and
thrombectomy using total hepatic vascular exclusion and
chemotherapy alone in patients with hepatocellular carcinoma and
tumor thrombi in the inferior vena cava and hepatic vein. Eur J
Gastroenterol Hepatol. 24:186–194. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Luo G, Chao YL, Tang B, Li BS, Xiao YF,
Xie R, Wang SM, Wu YY, Dong H, Liu XD, et al: miR-149 represses
metastasis of hepatocellular carcinoma by targeting
actin-regulatory proteins PPM1F. Oncotarget. 6:37808–37823. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li T, Xie J, Shen C, Cheng D, Shi Y, Wu Z,
Deng X, Chen H, Shen B, Peng C, et al: Amplification of long
noncoding RNA ZFAS1 promotes metastasis in hepatocellular
carcinoma. Cancer Res. 75:3181–3191. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shimada S, Kamiyama T, Yokoo H, Wakayama
K, Tsuruga Y, Kakisaka T, Kamachi H and Taketomi A:
Clinicopathological characteristics and prognostic factors in young
patients after hepatectomy for hepatocellular carcinoma. World J
Surg Oncol. 11:522013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Guan X: Cancer metastases: Challenges and
opportunities. Acta Pharm Sin B. 5:402–418. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mitra A, Mishra L and Li S: EMT, CTCs and
CSCs in tumor relapse and drug-resistance. Oncotarget.
6:10697–10711. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Su Z, Yang Z, Xu Y, Chen Y and Yu Q:
Apoptosis, autophagy, necroptosis, and cancer metastasis. Mol
Cancer. 14:482015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bao YX, Cao Q, Yang Y, Mao R, Xiao L,
Zhang H, Zhao HR and Wen H: Expression and prognostic significance
of golgiglycoprotein73 (GP73) with epithelial-mesenchymal
transition (EMT) related molecules in hepatocellular carcinoma
(HCC). Diagn Pathol. 8:1972013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang PF, Li KS, Shen YH, Gao PT, Dong ZR,
Cai JB, Zhang C, Huang XY, Tian MX, Hu ZQ, et al: Galectin-1
induces hepatocellular carcinoma EMT and sorafenib resistance by
activating FAK/PI3K/AKT signaling. Cell Death Dis. 7:e22012016.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yan J, Zhang Y, Zhang JP, Liang J, Li L
and Zheng L: Tim-3 expression defines regulatory T cells in human
tumors. PLoS One. 8:e580062013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liao J, Zhang Q, Liao Y, Cai B, Chen J, Li
L and Wang L: Association of T-cell immunoglobulin and mucin
domain-containing molecule 3 (Tim-3) polymorphisms with
susceptibility and disease progression of HBV infection. PLoS One.
9:e982802014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li Z, Liu Z, Zhang G, Han Q, Li N, Zhu Q,
Lv Y, Chen J, Xing F, Wang Y, et al: TIM3 gene polymorphisms in
patients with chronic hepatitis B virus infection: Impact on
disease susceptibility and hepatocellular carcinoma traits. Tissue
Antigens. 80:151–157. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shang Y, Li Z, Li H, Xia H and Lin Z:
TIM-3 expression in human osteosarcoma: Correlation with the
expression of epithelial-mesenchymal transition-specific
biomarkers. Oncol Lett. 6:490–494. 2013.PubMed/NCBI
|
|
20
|
Wang JC, Wang Z, Fan YX, Si YQ and Wang
JX: DNA methyltransferase 3b silencing affects locus-specific DNA
methylation and inhibits proliferation, migration and invasion in
human hepatocellular carcinoma SMMC-7721 and BEL-7402 cells. Oncol
Lett. 9:2499–2506. 2015.PubMed/NCBI
|
|
21
|
Gui R, Li D, Qi G, Suhad A and Nie X:
Inhibition of Grb2-mediated activation of MAPK signal transduction
suppresses NOR1/CB1954-induced cytotoxicity in the HepG2 cell line.
Oncol Lett. 4:566–570. 2012.PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2-ΔΔCt method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shan B, Man H, Liu J, Wang L, Zhu T, Ma M,
Xv Z, Chen X, Yang X and Li P: TIM-3 promotes the metastasis of
esophageal squamous cell carcinoma by targeting
epithelial-mesenchymal transition via the Akt/GSK-3β/Snail
signaling pathway. Oncol Rep. 36:1551–1561. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Song G, Cao HX, Yao SX and Li CT: Abnormal
expression of WIF1 in hepatocellular carcinoma cells and its
regulating effect on invasion and metastasis factors of TIMP-3 and
caveolin-1 of hepatocellular carcinoma. Asian Pac J Trop Med.
8:958–963. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li WX, Chen LP, Sun MY, Li JT, Liu HZ and
Zhu W: 3′3-Diindolylmethane inhibits migration, invasion and
metastasis of hepatocellular carcinoma by suppressing FAK
signaling. Oncotarget. 6:23776–23792. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gao Y, Ruan B, Liu W, Wang J, Yang X,
Zhang Z, Li X, Duan J, Zhang F, Ding R, et al: Knockdown of CD44
inhibits the invasion and metastasis of hepatocellular carcinoma
both in vitro and in vivo by reversing epithelial-mesenchymal
transition. Oncotarget. 6:7828–7837. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Feitelson MA, Sun B, Tufan Satiroglu NL,
Liu J, Pan J and Lian Z: Genetic mechanisms of
hepatocarcinogenesis. Oncogene. 21:2593–2604. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li Z, Li N, Zhu Q, Zhang G, Han Q, Zhang
P, Xun M, Wang Y, Zeng X, Yang C, et al: Genetic variations of PD1
and TIM3 are differentially and interactively associated with the
development of cirrhosis and HCC in patients with chronic HBV
infection. Infect Genet Evol. 14:240–246. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li Z, Li N, Li F, Zhou Z, Sang J, Chen Y,
Han Q, Lv Y and Liu Z: Immune checkpoint proteins PD-1 and TIM-3
are both highly expressed in liver tissues and correlate with their
gene polymorphisms in patients with HBV-related hepatocellular
carcinoma. Medicine (Baltimore). 95:e57492016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li Z, Li N, Li F, Zhou Z, Sang J, Jin Z,
Liu H, Han Q, Lv Y and Liu Z: Genetic polymorphisms of immune
checkpoint proteins PD-1 and TIM-3 are associated with survival of
patients with hepatitis B virus-related hepatocellular carcinoma.
Oncotarget. 7:26168–26180. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wittmann P, Grubinger M, Gröger C, Huber
H, Sieghart W, Peck-Radosavljevic M and Mikulits W: Neuropilin-2
induced by transforming growth factor-β augments migration of
hepatocellular carcinoma cells. BMC Cancer. 15:9092015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang Y and Shang Y: Epigenetic control of
epithelial-to-mesenchymal transition and cancer metastasis. Exp
Cell Res. 319:160–169. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wu L, Zheng J, Chen P, Liu Q and Yuan Y:
Small nucleolar RNA ACA11 promotes proliferation, migration and
invasion in hepatocellular carcinoma by targeting the PI3K/AKT
signaling pathway. Biomed Pharmacother. 90:705–712. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sajadian SO, Tripura C, Samani FS, Ruoss
M, Dooley S, Baharvand H and Nussler AK: Vitamin C enhances
epigenetic modifications induced by 5-azacytidine and cell cycle
arrest in the hepatocellular carcinoma cell lines HLE and Huh7.
Clin Epigenetics. 8:462016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Nath A, Li I, Roberts LR and Chan C:
Elevated free fatty acid uptake via CD36 promotes
epithelial-mesenchymal transition in hepatocellular carcinoma. Sci
Rep. 5:147522015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wu Y, Liu H, Weng H, Zhang X, Li P, Fan
CL, Li B, Dong PL, Li L, Dooley S, et al: Glypican-3 promotes
epithelial-mesenchymal transition of hepatocellular carcinoma cells
through ERK signaling pathway. Int J Oncol. 46:1275–1285.
2015.PubMed/NCBI
|
|
37
|
Yun SJ and Kim WJ: Role of the
epithelial-mesenchymal transition in bladder cancer: From prognosis
to therapeutic target. Korean J Urol. 54:645–650. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhang Z, Bu X, Chen H, Wang Q and Sha W:
Bmi-1 promotes the invasion and migration of colon cancer stem
cells through the downregulation of E-cadherin. Int J Mol Med.
38:1199–1207. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wu CL, Ho JY, Chou SC and Yu DS: miR-429
reverses epithelial-mesenchymal transition by restoring E-cadherin
expression in bladder cancer. Oncotarget. 7:26593–26603. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Grant CM and Kyprianou N: Epithelial
mesenchymal transition (EMT) in prostate growth and tumor
progression. Transl Androl Urol. 2:202–211. 2013.PubMed/NCBI
|
|
41
|
Miyoshi A, Kitajima Y, Kido S, Shimonishi
T, Matsuyama S, Kitahara K and Miyazaki K: Snail accelerates cancer
invasion by upregulating MMP expression and is associated with poor
prognosis of hepatocellular carcinoma. Br J Cancer. 92:252–258.
2005.PubMed/NCBI
|
|
42
|
Behnsawy HM, Miyake H, Harada K and
Fujisawa M: Expression patterns of epithelial-mesenchymal
transition markers in localized prostate cancer: Significance in
clinicopathological outcomes following radical prostatectomy. BJU
Int. 111:30–37. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
McConkey DJ, Choi W, Marquis L, Martin F,
Williams MB, Shah J, Svatek R, Das A, Adam L, Kamat A, et al: Role
of epithelial-to-mesenchymal transition (EMT) in drug sensitivity
and metastasis in bladder cancer. Cancer Metastasis Rev.
28:335–344. 2009. View Article : Google Scholar : PubMed/NCBI
|
